GlaxoSmithKline CEO: Strong Currency Tailwind Effect

The video discusses GSK's financial strategies, including the impact of a weaker pound on revenue, dividend expectations, and cash deployment. It contrasts mergers and acquisitions with organic growth, emphasizing investment in R&D. The video highlights GSK's innovative product pipeline and addresses the implications of Brexit on the business environment, affirming the UK as a favorable location for operations.

What is the significance of the Shingrix vaccine for GSK?

What are the expected benefits of GSK's investment in facilities in the UK?

How does GSK view the regulatory environment in the UK post-Brexit?